Readystate Asset Management LP Janux Therapeutics, Inc. Transaction History
Readystate Asset Management LP
- $3.27 Trillion
- Q2 2025
A detailed history of Readystate Asset Management LP transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Readystate Asset Management LP holds 695,956 shares of JANX stock, worth $15.9 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
695,956
Previous 276,560
151.65%
Holding current value
$15.9 Million
Previous $7.47 Billion
115.3%
% of portfolio
0.49%
Previous 0.25%
Shares
4 transactions
Others Institutions Holding JANX
# of Institutions
190Shares Held
57.9MCall Options Held
626KPut Options Held
155K-
Ra Capital Management, L.P. Boston, MA11.2MShares$255 Million6.27% of portfolio
-
Janus Henderson Group PLC London, X04.6MShares$105 Million0.07% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.65MShares$83.4 Million0.19% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.33MShares$76 Million4.61% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$53.5 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $951M
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...